Clinical Report: Initial Insights on the Use of Tubridge Plus Flow Diverter
Overview
This study evaluates the Tubridge Plus flow diverter (TPFD) for treating intracranial aneurysms (IAs), reporting a 100% technical success rate and progressive improvement in occlusion rates over time.
Background
Intracranial aneurysms pose significant risks, including subarachnoid hemorrhage, leading to high morbidity and mortality. The management of these aneurysms, particularly those with complex morphology, remains challenging. Flow diverters have transformed the endovascular treatment landscape, offering new therapeutic mechanisms for previously difficult cases.
Data Highlights
Outcome
Rate
Technical success rate
100%
Intraoperative adverse events
20%
Complete occlusion at 6 months
60%
Complete occlusion at 1 year
80%
Complete occlusion at last FU
90%
Adequate occlusion at 1 year
90%
Adequate occlusion at last FU
100%
Key Findings
Technical success rate for TPFD delivery was 100%.
Intraoperative adverse events occurred in 20% of patients, managed successfully with adjunctive stenting.
No perioperative complications were reported.
Complete occlusion rates improved to 90% by the last follow-up.
No in-stent stenosis or ipsilateral stroke occurred during follow-up.
Clinical Implications
The TPFD achieved a technical success rate of 100% and complete occlusion rates of 60% at 6 months, 80% at 1 year, and 90% at the last follow-up.
Conclusion
This study reports a technical success rate of 100% for TPFD in treating intracranial aneurysms, with complete occlusion rates improving over time.
